CACNB2 and Behcet disease: CACNB2 is a validated target of miR‐499‐5p in cardiomyocytes (Ling et al, 2017) and in a very recent GWAS with more than 40,000 BD patients, the CACNB2 locus was significantly associated with BD (Mullins et al, 2021).